Skip to main content

Table 1 Demographic and clinical data of the studied groups

From: Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study

 

SCT Group I

(n= 50)

SMT Group II

(n= 50)

Healthy volunteers Group III

(n= 50)

P value

Age (mean ± SD)

51.84 ± 7.57

50.36 ± 7.01

46.40 ± 10.77

> 0.05

Gender (%)

    

Male

42 (84%)

40 (80%)

40 (80%)

> 0.05

Female

8 (16%)

10 (20%)

10 (20%)

 

Residency (%)

    

Urban

38 (76%)

39 (78%)

40 (80%)

> 0.05

Rural

12 (24%)

11 (22%)

10 (20%)

 

Occupation (%)

    

Administrative, managerial, and professional

23 (46%)

23 (46%)

26 (52%)

> 0.05

Other occupations

27 (54%)

27 (54%)

24 (48%)

 

Marital status (%)

    

Married

50 (100%)

50 (100%)

46 (92%)

> 0.05

Unmarried

0 (0)

0 (0)

6 (8%)

 

Jaundice

24

22

 

> 0.05

History of encephalopathy

12

20

 

> 0.05

Weight loss

32

29

 

> 0.05

Peripheral erythema

42

39

 

> 0.05

Lower-limb edema

32

33

 

> 0.05